We are live on !
Find out more
Pitcairn Portfolio holdings
AUM
$1.27B
Turnover
17.93%
1-Year Est. Return
23.64%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
+23.64%
3 Year Est. Return
+111.21%
5 Year Est. Return
+126.49%
10 Year Est. Return
+390.86%
AUM
$833M
AUM Growth
+$7.36M
(+0.89%)
Cap. Flow
-$24.9M
Cap. Flow % of AUM
Cap. Flow %
-2.99%
Top 10 Holdings %
Top 10 Hldgs %
52.45%
Holding
520
New
34
Increased
100
Reduced
321
Closed
48
Avg Time Held
2.4
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$3.57M |
| 2 |
Intuit
INTU
|
+$2.04M |
| 3 |
Cadence Design Systems
CDNS
|
+$1.21M |
| 4 |
Gilead Sciences
GILD
|
+$1.12M |
| 5 |
Steel Dynamics
STLD
|
+$778K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$3.05M |
| 2 |
NXP Semiconductors
NXPI
|
+$2.76M |
| 3 |
Akamai
AKAM
|
+$1.93M |
| 4 |
TE Connectivity
TEL
|
+$1.92M |
| 5 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$1.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.46% |
| 2 | Consumer Staples | 24.59% |
| 3 | Financials | 10.26% |
| 4 | Technology | 8.78% |
| 5 | Healthcare | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
iShares Russell 3000 ETF
IWV
$20.4B
| $159M | 19.13% |
1,106,295
+2,825
| +0.3% | +$402K |
2013 Q2
16 quarters
|
|
2
Brown-Forman Class A
BF.A
$13.2B
| $141M | 16.96% |
3,581,121
| – | – |
2013 Q2
16 quarters
|
|
3
Brown-Forman Class B
BF.B
$12.9B
| $36.1M | 4.33% |
1,159,180
-90
| -0% | -$2.82K |
2013 Q2
16 quarters
|
|
4
iShares Russell 1000 ETF
IWB
$48.9B
| $25.6M | 3.07% |
189,236
-3,471
| -2% | -$463K |
2013 Q2
16 quarters
|
|
5
iShares Russell 1000 Value ETF
IWD
$84.3B
| $20.2M | 2.43% |
173,632
-999
| -0.6% | -$115K |
2017 Q1
1 quarter
|
|
6
Berkshire Hathaway Class A
BRK.A
$1.16T
| $14.5M | 1.74% |
57
| – | – |
2013 Q2
16 quarters
|
|
7
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.86B
| $13.2M | 1.59% |
556,466
+19,097
| +4% | +$449K |
2013 Q2
16 quarters
|
|
8
Amazon
AMZN
$2.83T
| $9.27M | 1.11% |
191,600
-9,920
| -5% | -$473K |
2013 Q2
16 quarters
|
|
9
Meta Platforms (Facebook)
META
$1.77T
| $8.8M | 1.06% |
58,314
-67
| -0.1% | -$10K |
2013 Q2
16 quarters
|
|
10
Vanguard Russell 3000 ETF
VTHR
$4.92B
| $8.52M | 1.02% |
76,488
-1,417
| -2% | -$156K |
2016 Q2
4 quarters
|
|
11
Visa
V
$763B
| $8.03M | 0.96% |
85,593
-4,248
| -5% | -$394K |
2013 Q2
16 quarters
|
|
12
Apple
AAPL
$4.95T
| $7.17M | 0.86% |
199,072
+6,184
| +3% | +$229K |
2013 Q2
16 quarters
|
|
13
Vanguard Morningstar Total Stock Market ETF
VTI
$695B
| $6.1M | 0.73% |
49,057
-22
| -0% | -$2.71K |
2013 Q2
16 quarters
|
|
14
Adobe
ADBE
$100B
| $5.46M | 0.66% |
38,611
+3,498
| +10% | +$479K |
2013 Q2
16 quarters
|
|
15
Alphabet (Google) Class A
GOOGL
$4.16T
| $5.33M | 0.64% |
114,600
-4,300
| -4% | -$201K |
2015 Q4
6 quarters
|
|
16
Intuitive Surgical
ISRG
$155B
| $4.75M | 0.57% |
45,666
-81
| -0.2% | -$7.78K |
2013 Q2
16 quarters
|
|
17
Johnson & Johnson
JNJ
$625B
| $4.75M | 0.57% |
35,879
-75
| -0.2% | -$9.6K |
2013 Q2
16 quarters
|
|
18
Alphabet (Google) Class C
GOOG
$4.11T
| $4.68M | 0.56% |
103,080
-1,260
| -1% | -$57.7K |
2013 Q2
16 quarters
|
|
19
JPMorgan Chase
JPM
$890B
| $4.57M | 0.55% |
50,043
+231
| +0.5% | +$19.9K |
2013 Q2
16 quarters
|
|
20
Salesforce
CRM
$200B
| $4.4M | 0.53% |
50,747
-25
| -0% | -$2.18K |
2013 Q2
16 quarters
|
|
21
Microsoft
MSFT
$3.95T
| $4.3M | 0.52% |
62,395
-1,216
| -2% | -$83.5K |
2013 Q2
16 quarters
|
|
22
Danaher
DHR
$158B
| $4.19M | 0.5% |
56,065
+2,415
| +5% | +$181K |
2013 Q2
16 quarters
|
|
23
Valero Energy
VLO
$125B
| $3.87M | 0.46% |
57,342
+5,458
| +11% | +$354K |
2013 Q2
16 quarters
|
|
|
24
Zoetis
ZTS
$33.1B
| $3.78M | 0.45% |
+60,519
| New | +$3.57M |
2017 Q2
0 quarters
|
|
25
PayPal
PYPL
$48.9B
| $3.61M | 0.43% |
67,232
+5,411
| +9% | +$266K |
2015 Q3
7 quarters
|
|
Similar funds
Pitcairn's Q2 2017 Portfolio in Review
As of Q2 2017, Pitcairn held 520 positions worth $833M, up 0.89% from $825M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Pitcairn's Q2 2017 filing shows 34 new, 100 increased, 321 reduced and 48 closed positions. Its largest new stake was Zoetis: 60,519 shares worth $3.78M. The largest sale was LyondellBasell Industries, an estimated $3.05M.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 29% a quarter earlier, followed by Consumer Staples and Financials.
- Pitcairn's largest Q2 2017 buy was Zoetis: 60,519 shares worth $3.78M.
- Pitcairn added most to Intuit in Q2 2017, an estimated $2.04M increase.
- Pitcairn's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $1.54M.
- Pitcairn fully exited LyondellBasell Industries in Q2 2017, selling an estimated $3.05M.
- Pitcairn's ten largest holdings make up 52% of its $833M portfolio in Q2 2017.
- Pitcairn opened 34 new positions and closed 48 in Q2 2017.
- Pitcairn's portfolio value rose 0.89% quarter-over-quarter to $833M.
Based on Pitcairn's 13F filing for Q2 2017, filed 2 Aug 2017.